{"schemaVersion":"wpf-profile-export-v1","exportedAt":"2026-09-18T15:30:59.255Z","profile":{"slug":"elamipretide","name":"Elamipretide","aliases":[],"category":"Mitochondria-targeting peptide"},"synthesis":{"mechanism":"Mitochondria-targeting aromatic-cationic tetrapeptide that interacts with cardiolipin; evidence is separated by disease and endpoint.","evidence":"Source identities are PubMed-resolved and provisionally graded by study design. Full-text findings, bias, applicability, contradictions, and regulatory interpretation remain pending.","safety":"US accelerated approval for a limited Barth-syndrome population must not be generalized to other proposed uses.","observationalBoundary":"A minimum 25-source PubMed corpus and chemistry record are staged for accountable review. This profile remains suppressed until authorized scientific and publication approval.","openQuestions":"Which findings survive full-text risk-of-bias review? Which populations, formulations, routes, doses, comparators, durations, and endpoints are directly supported? What jurisdiction-specific authorization applies?"},"completion":{"version":"wpf-profile-v1.0","complete":false,"checks":[{"key":"overview","passed":true,"actual":133,"required":100,"severity":"blocking"},{"key":"evidence_summary","passed":true,"actual":182,"required":100,"severity":"blocking"},{"key":"safety_summary","passed":true,"actual":111,"required":100,"severity":"blocking"},{"key":"archive_boundary","passed":true,"actual":175,"required":75,"severity":"blocking"},{"key":"open_questions","passed":true,"actual":213,"required":75,"severity":"blocking"},{"key":"verified_sources","passed":true,"actual":25,"required":25,"severity":"blocking"},{"key":"reviewed_sources","passed":false,"actual":0,"required":1,"severity":"blocking"},{"key":"chemistry","passed":true,"actual":true,"required":true,"severity":"blocking"},{"key":"regulatory_context","passed":true,"actual":2,"required":2,"severity":"blocking"},{"key":"claims","passed":false,"actual":0,"required":1,"severity":"blocking"},{"key":"claim_traceability","passed":true,"actual":0,"required":0,"severity":"blocking"},{"key":"regulatory_freshness","passed":true,"actual":0,"required":0,"severity":"warning"}],"failures":["reviewed_sources","claims"]},"chemistry":{"id":"9f7c06bf6b7e42f5ade3a893b0767c8f","peptideId":"9c8a568e-7c1f-4369-8489-e86b54b71580","molecularFormula":"C32H49N9O5","molecularWeight":639.8,"aminoAcidSequence":null,"smiles":null,"inchi":null,"inchikey":"SFVLTCAESLKEHH-WKAQUBQDSA-N","structureImageUrl":null,"createdAt":"2026-09-09T11:44:22.278Z","updatedAt":"2026-09-09T11:44:22.278Z"},"evidence":[{"id":"eecd1642-ba4f-5288-9be0-c118925c4013","peptideId":"9c8a568e-7c1f-4369-8489-e86b54b71580","title":"Elamipretide: First Approval.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/41335372/","evidenceTier":"observational","summary":"PubMed-indexed journal article; review examining elamipretide: first approval. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"Matt Shirley","publishingOrg":"Drugs","publicationYear":2026,"doi":"10.1002/jcsm.12559","pubmedId":"41335372","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:17.424Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1002/jcsm.12559","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:17.424Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"mechanistic","extractionPayload":{"sourceStrength":{"grade":"B","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Journal Article; Review"},"provenancePayload":{"doi":"10.1002/jcsm.12559","pmid":"41335372","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:17.424Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"d3b1548d-19cf-570e-a758-c241cc5ac9c6","peptideId":"9c8a568e-7c1f-4369-8489-e86b54b71580","title":"Is an emerging pharmacotherapeutic era for rare mitochondrial diseases here?","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/42229401/","evidenceTier":"observational","summary":"PubMed-indexed journal article examining is an emerging pharmacotherapeutic era for rare mitochondrial diseases here?. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"Jirair K Bedoyan; Jerry Vockley","publishingOrg":"Cell metabolism","publicationYear":2026,"doi":"10.1016/j.cmet.2026.04.014","pubmedId":"42229401","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:17.424Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1016/j.cmet.2026.04.014","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:17.424Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"mechanistic","extractionPayload":{"sourceStrength":{"grade":"C","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Journal Article"},"provenancePayload":{"doi":"10.1016/j.cmet.2026.04.014","pmid":"42229401","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:17.424Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"58591526-3bbd-5cb0-9c74-47dbe66d93de","peptideId":"9c8a568e-7c1f-4369-8489-e86b54b71580","title":"RePOWER: An International, Prospective, Non-Interventional Registry of Patients With Primary Mitochondrial Myopathy.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/40785393/","evidenceTier":"observational","summary":"PubMed-indexed journal article; multicenter study; observational study; research support, non-u.s. gov't examining repower: an international, prospective, non-interventional registry of patients with primary mitochondrial myopathy. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"Amel Karaa; Amy Goldstein; Bruce H Cohen; Richard H Haas; Jerry Vockley; Gráinne S Gorman; Michelangelo Mancuso; RePOWER, MMPOWER‐3, and MOTOR investigators","publishingOrg":"Clinical genetics","publicationYear":2026,"doi":"10.1111/cge.70026","pubmedId":"40785393","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:17.424Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1111/cge.70026","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:17.424Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"mechanistic","extractionPayload":{"sourceStrength":{"grade":"C","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Journal Article; Multicenter Study; Observational Study; Research Support, Non-U.S. Gov't"},"provenancePayload":{"doi":"10.1111/cge.70026","pmid":"40785393","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:17.424Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"4cfca990-9338-51b3-8e5d-78bce3ad103f","peptideId":"9c8a568e-7c1f-4369-8489-e86b54b71580","title":"Safety and Efficacy of Approved and Unapproved Peptide Therapies for Musculoskeletal Injuries and Athletic Performance.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/41966639/","evidenceTier":"observational","summary":"PubMed-indexed journal article; review examining safety and efficacy of approved and unapproved peptide therapies for musculoskeletal injuries and athletic performance. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"Christopher L Mendias; Tariq M Awan","publishingOrg":"Sports medicine (Auckland, N.Z.)","publicationYear":2026,"doi":"10.1038/sj.embor.7400236","pubmedId":"41966639","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:17.424Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1038/sj.embor.7400236","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:17.424Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"mechanistic","extractionPayload":{"sourceStrength":{"grade":"B","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Journal Article; Review"},"provenancePayload":{"doi":"10.1038/sj.embor.7400236","pmid":"41966639","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:17.424Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"527f6e9b-f7dc-55a6-b9dd-04caa41fe182","peptideId":"9c8a568e-7c1f-4369-8489-e86b54b71580","title":"Synergistic mitochondrial homeostasis regulation and cholinergic circuits reconstruction via a one-step synthesized multifunctional hydrogel facilitates spinal cord injury repair.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/41551770/","evidenceTier":"observational","summary":"PubMed-indexed journal article examining synergistic mitochondrial homeostasis regulation and cholinergic circuits reconstruction via a one-step synthesized multifunctional hydrogel facilitates spinal cord injury repair. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"Yiqian Luo; Pan Jiang; Daoqiang Huang; Hong Li; Jiale He; Ruoqi Shen; Yunheng Jiang; Limin Rong; Bin Liu","publishingOrg":"Bioactive materials","publicationYear":2026,"doi":"10.1016/j.bioactmat.2025.12.009","pubmedId":"41551770","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:17.424Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1016/j.bioactmat.2025.12.009","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:17.424Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"mechanistic","extractionPayload":{"sourceStrength":{"grade":"C","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Journal Article"},"provenancePayload":{"doi":"10.1016/j.bioactmat.2025.12.009","pmid":"41551770","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:17.424Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"a4469310-7ed6-5694-8be0-fb8482eae10a","peptideId":"9c8a568e-7c1f-4369-8489-e86b54b71580","title":"Elamipretide: A Review of Its Structure, Mechanism of Action, and Therapeutic Potential.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/39940712/","evidenceTier":"observational","summary":"PubMed-indexed journal article; review examining elamipretide: a review of its structure, mechanism of action, and therapeutic potential. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"Cheryl Tung; Fahimeh Varzideh; Emanuele Farroni; Pasquale Mone; Urna Kansakar; Stanislovas S Jankauskas; Gaetano Santulli","publishingOrg":"International journal of molecular sciences","publicationYear":2025,"doi":"10.1161/CIRCINTERVENTIONS.117.005487","pubmedId":"39940712","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:17.424Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1161/circinterventions.117.005487","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:17.424Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"mechanistic","extractionPayload":{"sourceStrength":{"grade":"B","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Journal Article; Review"},"provenancePayload":{"doi":"10.1161/CIRCINTERVENTIONS.117.005487","pmid":"39940712","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:17.424Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"e1ff9013-2c47-5a81-b1ff-0f1322f62096","peptideId":"9c8a568e-7c1f-4369-8489-e86b54b71580","title":"Examination of mitochondria- and inflammasome-mediated mechanisms of clozapine-induced myocarditis using patient-derived iPSC cardiomyocytes.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/39962181/","evidenceTier":"observational","summary":"PubMed-indexed journal article examining examination of mitochondria- and inflammasome-mediated mechanisms of clozapine-induced myocarditis using patient-derived ipsc cardiomyocytes. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"Nazanin Vaziri; Timothy E Shutt; Wasi Karim; Thomas J Raedler; Christos Pantelis; Naveen Thomas; Mahesh Jayaram; Steven C Greenway; Chad A Bousman","publishingOrg":"Molecular psychiatry","publicationYear":2025,"doi":"10.1038/s41380-025-02935-z","pubmedId":"39962181","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:17.424Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1038/s41380-025-02935-z","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:17.424Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"mechanistic","extractionPayload":{"sourceStrength":{"grade":"C","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Journal Article"},"provenancePayload":{"doi":"10.1038/s41380-025-02935-z","pmid":"39962181","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:17.424Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"c7add383-1301-52ca-8705-287694ccae3e","peptideId":"9c8a568e-7c1f-4369-8489-e86b54b71580","title":"Mitochondrial Dysfunction: The Silent Catalyst of Kidney Disease Progression.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/40497970/","evidenceTier":"observational","summary":"PubMed-indexed journal article; review; research support, non-u.s. gov't examining mitochondrial dysfunction: the silent catalyst of kidney disease progression. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"Nikola Pavlović; Marinela Križanac; Marko Kumrić; Katarina Vukojević; Joško Božić","publishingOrg":"Cells","publicationYear":2025,"doi":"10.4103/ijot.ijot_37_23","pubmedId":"40497970","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:17.424Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.4103/ijot.ijot_37_23","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:17.424Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"mechanistic","extractionPayload":{"sourceStrength":{"grade":"B","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Journal Article; Review; Research Support, Non-U.S. Gov't"},"provenancePayload":{"doi":"10.4103/ijot.ijot_37_23","pmid":"40497970","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:17.424Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"2408a6cf-46ea-57df-9149-a1ec838ace32","peptideId":"9c8a568e-7c1f-4369-8489-e86b54b71580","title":"SS-31 Targets NOS2 to Enhance Osteogenic Differentiation in Aged BMSCs by Restoring Mitochondrial Function.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/40570323/","evidenceTier":"observational","summary":"PubMed-indexed journal article examining ss-31 targets nos2 to enhance osteogenic differentiation in aged bmscs by restoring mitochondrial function. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"Sen Duan; Qindong Zhang; Jinqiang Zhu; Jiaming Wang","publishingOrg":"Organogenesis","publicationYear":2025,"doi":"10.1073/pnas.2207993120","pubmedId":"40570323","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:17.424Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1073/pnas.2207993120","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:17.424Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"mechanistic","extractionPayload":{"sourceStrength":{"grade":"C","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Journal Article"},"provenancePayload":{"doi":"10.1073/pnas.2207993120","pmid":"40570323","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:17.424Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"5cc8652c-a675-59b6-b29a-de1fcb2ee380","peptideId":"9c8a568e-7c1f-4369-8489-e86b54b71580","title":"SS-31@Fer-1 Alleviates ferroptosis in hypoxia/reoxygenation cardiomyocytes via mitochondrial targeting.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/39848110/","evidenceTier":"observational","summary":"PubMed-indexed journal article examining ss-31@fer-1 alleviates ferroptosis in hypoxia/reoxygenation cardiomyocytes via mitochondrial targeting. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"Hao Zheng; Jinbo Ou; Hui Han; Qizheng Lu; Yunli Shen","publishingOrg":"Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie","publicationYear":2025,"doi":"10.1016/j.biopha.2025.117832","pubmedId":"39848110","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:17.424Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1016/j.biopha.2025.117832","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:17.424Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"mechanistic","extractionPayload":{"sourceStrength":{"grade":"C","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Journal Article"},"provenancePayload":{"doi":"10.1016/j.biopha.2025.117832","pmid":"39848110","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:17.424Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"0d21e5cd-1074-5589-9ea9-5cab8d89ac05","peptideId":"9c8a568e-7c1f-4369-8489-e86b54b71580","title":"Targeting ANT1 to regulate PINK1/Parkin-mediated mitophagy is an effective treatment of trauma-induced tendon heterotopic ossification.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/41542093/","evidenceTier":"observational","summary":"PubMed-indexed journal article examining targeting ant1 to regulate pink1/parkin-mediated mitophagy is an effective treatment of trauma-induced tendon heterotopic ossification. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"Guanzhi Li; Tong Li; Ye Deng; Xiao Deng; Chao Chen; Bin Yu; Kairui Zhang","publishingOrg":"Journal of orthopaedic translation","publicationYear":2025,"doi":"10.1093/eurheartj/ehv597","pubmedId":"41542093","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:17.424Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1093/eurheartj/ehv597","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:17.424Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"mechanistic","extractionPayload":{"sourceStrength":{"grade":"C","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Journal Article"},"provenancePayload":{"doi":"10.1093/eurheartj/ehv597","pmid":"41542093","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:17.424Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"61ea4cf4-f5aa-58df-93c9-0203e0659cb6","peptideId":"9c8a568e-7c1f-4369-8489-e86b54b71580","title":"Telomere length in offspring is determined by mitochondrial-nuclear communication at fertilization.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/40087268/","evidenceTier":"observational","summary":"PubMed-indexed journal article examining telomere length in offspring is determined by mitochondrial-nuclear communication at fertilization. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"Yasmyn E Winstanley; Ryan D Rose; Alexander P Sobinoff; Linda L Wu; Deepak Adhikari; Qing-Hua Zhang; Jadon K Wells; Lee H Wong; Hazel H Szeto; Sandra G Piltz; Paul Q Thomas; Mark A Febbraio","publishingOrg":"Nature communications","publicationYear":2025,"doi":"10.1038/s41588-018-0055-6","pubmedId":"40087268","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:17.424Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1038/s41588-018-0055-6","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:17.424Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"mechanistic","extractionPayload":{"sourceStrength":{"grade":"C","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Journal Article"},"provenancePayload":{"doi":"10.1038/s41588-018-0055-6","pmid":"40087268","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:17.424Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"9aab49df-606b-57dc-b1de-34ff744a9303","peptideId":"9c8a568e-7c1f-4369-8489-e86b54b71580","title":"ALCAT1-mediated abnormal cardiolipin remodelling promotes mitochondrial injury in podocytes in diabetic kidney disease.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/38200543/","evidenceTier":"observational","summary":"PubMed-indexed video-audio media; journal article; research support, non-u.s. gov't examining alcat1-mediated abnormal cardiolipin remodelling promotes mitochondrial injury in podocytes in diabetic kidney disease. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"Yiqun Hao; Yanqin Fan; Jun Feng; Zijing Zhu; Zilv Luo; Hongtu Hu; Weiwei Li; Hongxia Yang; Guohua Ding","publishingOrg":"Cell communication and signaling : CCS","publicationYear":2024,"doi":"10.1186/s12964-023-01399-4","pubmedId":"38200543","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:17.424Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1186/s12964-023-01399-4","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:17.424Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"mechanistic","extractionPayload":{"sourceStrength":{"grade":"C","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Video-Audio Media; Journal Article; Research Support, Non-U.S. Gov't"},"provenancePayload":{"doi":"10.1186/s12964-023-01399-4","pmid":"38200543","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:17.424Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"5b84a5fe-e7f9-5329-89ab-04e84e07da71","peptideId":"9c8a568e-7c1f-4369-8489-e86b54b71580","title":"Effect of Aficamten on Health Status Outcomes in Obstructive Hypertrophic Cardiomyopathy: Results From SEQUOIA-HCM.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/39217569/","evidenceTier":"phase_3","summary":"PubMed-indexed journal article; randomized controlled trial; clinical trial, phase iii; multicenter study examining effect of aficamten on health status outcomes in obstructive hypertrophic cardiomyopathy: results from sequoia-hcm. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"Charles F Sherrod; Sara Saberi; Michael E Nassif; Brian L Claggett; Caroline J Coats; Pablo Garcia-Pavia; James L Januzzi; Gregory D Lewis; Changsheng Ma; Martin S Maron; Zi Michael Miao; Iacopo Olivotto","publishingOrg":"Journal of the American College of Cardiology","publicationYear":2024,"doi":"10.1016/j.jacc.2021.10.045","pubmedId":"39217569","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:17.424Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1016/j.jacc.2021.10.045","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:17.424Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"human_interventional","extractionPayload":{"sourceStrength":{"grade":"A","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Multicenter Study"},"provenancePayload":{"doi":"10.1016/j.jacc.2021.10.045","pmid":"39217569","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:17.424Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"d34cf3c6-c188-5d0d-ae59-139b7b34d14d","peptideId":"9c8a568e-7c1f-4369-8489-e86b54b71580","title":"Genome-Wide CRISPR Screen Identifies Phospholipid Scramblase 3 as the Biological Target of Mitoprotective Drug SS-31.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/38530359/","evidenceTier":"observational","summary":"PubMed-indexed letter; research support, non-u.s. gov't; research support, n.i.h., extramural examining genome-wide crispr screen identifies phospholipid scramblase 3 as the biological target of mitoprotective drug ss-31. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"Josie A Silvaroli; Bijay Bisunke; Ji Young Kim; Amanda Stayton; Laura A Jayne; Shirely A Martinez; Christopher Nguyen; Prisha S Patel; Thitinee Vanichapol; Vivek Verma; Juheb Akhter; Subhashini Bolisetty","publishingOrg":"Journal of the American Society of Nephrology : JASN","publicationYear":2024,"doi":"10.1021/bi701962c","pubmedId":"38530359","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:17.424Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1021/bi701962c","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:17.424Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"mechanistic","extractionPayload":{"sourceStrength":{"grade":"C","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Letter; Research Support, Non-U.S. Gov't; Research Support, N.I.H., Extramural"},"provenancePayload":{"doi":"10.1021/bi701962c","pmid":"38530359","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:17.424Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"be9a9d8a-9e4e-5aac-99d0-94aadd10b04c","peptideId":"9c8a568e-7c1f-4369-8489-e86b54b71580","title":"Genotype-specific effects of elamipretide in patients with primary mitochondrial myopathy: a post hoc analysis of the MMPOWER-3 trial.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/39574155/","evidenceTier":"phase_3","summary":"PubMed-indexed journal article; randomized controlled trial; clinical trial, phase iii; research support, n.i.h., extramural; research support, non-u.s. gov't examining genotype-specific effects of elamipretide in patients with primary mitochondrial myopathy: a post hoc analysis of the mmpower-3 trial. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"Amel Karaa; Enrico Bertini; Valerio Carelli; Bruce Cohen; Gregory M Ennes; Marni J Falk; Amy Goldstein; Gráinne Gorman; Richard Haas; Michio Hirano; Thomas Klopstock; Mary Kay Koenig","publishingOrg":"Orphanet journal of rare diseases","publicationYear":2024,"doi":"10.1002/crt2.41","pubmedId":"39574155","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:17.424Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1002/crt2.41","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:17.424Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"human_interventional","extractionPayload":{"sourceStrength":{"grade":"A","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Journal Article; Randomized Controlled Trial; Clinical Trial, Phase III; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't"},"provenancePayload":{"doi":"10.1002/crt2.41","pmid":"39574155","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:17.424Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"b6da02b6-4c8c-53a5-8335-f9433bcdaea5","peptideId":"9c8a568e-7c1f-4369-8489-e86b54b71580","title":"Efficacy and Safety of Elamipretide in Individuals With Primary Mitochondrial Myopathy: The MMPOWER-3 Randomized Clinical Trial.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/37268435/","evidenceTier":"phase_3","summary":"PubMed-indexed randomized controlled trial; clinical trial, phase iii; journal article; research support, non-u.s. gov't examining efficacy and safety of elamipretide in individuals with primary mitochondrial myopathy: the mmpower-3 randomized clinical trial. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"Amel Karaa; Enrico Bertini; Valerio Carelli; Bruce H Cohen; Gregory M Enns; Marni J Falk; Amy Goldstein; Gráinne Siobhan Gorman; Richard Haas; Michio Hirano; Thomas Klopstock; Mary Kay Koenig","publishingOrg":"Neurology","publicationYear":2023,"doi":"10.1101/2020.11.20.20235580","pubmedId":"37268435","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:17.424Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1101/2020.11.20.20235580","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:17.424Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"human_interventional","extractionPayload":{"sourceStrength":{"grade":"A","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Randomized Controlled Trial; Clinical Trial, Phase III; Journal Article; Research Support, Non-U.S. Gov't"},"provenancePayload":{"doi":"10.1101/2020.11.20.20235580","pmid":"37268435","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:17.424Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"060bc0ca-08ea-5a85-af5d-2a39e198ec5a","peptideId":"9c8a568e-7c1f-4369-8489-e86b54b71580","title":"A ROS-Responsive Liposomal Composite Hydrogel Integrating Improved Mitochondrial Function and Pro-Angiogenesis for Efficient Treatment of Myocardial Infarction.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/35848825/","evidenceTier":"observational","summary":"PubMed-indexed journal article; research support, non-u.s. gov't examining a ros-responsive liposomal composite hydrogel integrating improved mitochondrial function and pro-angiogenesis for efficient treatment of myocardial infarction. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"Zhi Zheng; Cai Lei; Hongbing Liu; Mingchao Jiang; Zongtao Zhou; Yuqi Zhao; Cui-Yun Yu; Hua Wei","publishingOrg":"Advanced healthcare materials","publicationYear":2022,"doi":"10.1002/adhm.202200990","pubmedId":"35848825","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:17.424Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1002/adhm.202200990","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:17.424Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"mechanistic","extractionPayload":{"sourceStrength":{"grade":"C","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Journal Article; Research Support, Non-U.S. Gov't"},"provenancePayload":{"doi":"10.1002/adhm.202200990","pmid":"35848825","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:17.424Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"85f89c7e-0230-515d-adbb-5d6138e2c0bb","peptideId":"9c8a568e-7c1f-4369-8489-e86b54b71580","title":"Elamipretide for Barth syndrome cardiomyopathy: gradual rebuilding of a failed power grid.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/34623544/","evidenceTier":"observational","summary":"PubMed-indexed journal article; review; research support, non-u.s. gov't examining elamipretide for barth syndrome cardiomyopathy: gradual rebuilding of a failed power grid. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"Hani N Sabbah","publishingOrg":"Heart failure reviews","publicationYear":2022,"doi":"10.1681/ASN.2016070761","pubmedId":"34623544","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:17.424Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1681/asn.2016070761","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:17.424Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"mechanistic","extractionPayload":{"sourceStrength":{"grade":"B","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Journal Article; Review; Research Support, Non-U.S. Gov't"},"provenancePayload":{"doi":"10.1681/ASN.2016070761","pmid":"34623544","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:17.424Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"5a7d90ff-84b3-5de5-829e-d8e31af564c0","peptideId":"9c8a568e-7c1f-4369-8489-e86b54b71580","title":"Quality of life in Barth syndrome.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/37180415/","evidenceTier":"observational","summary":"PubMed-indexed journal article examining quality of life in barth syndrome. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"Alexander Y Kim; Hilary Vernon; Ryan Manuel; Mohammed Almuqbil; Brittany Hornby","publishingOrg":"Therapeutic advances in rare disease","publicationYear":2022,"doi":"10.1177/26330040221093743","pubmedId":"37180415","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:17.424Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1177/26330040221093743","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:17.424Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"mechanistic","extractionPayload":{"sourceStrength":{"grade":"C","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Journal Article"},"provenancePayload":{"doi":"10.1177/26330040221093743","pmid":"37180415","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:17.424Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"f59d9741-578f-5033-b8e2-d03146ba8dd0","peptideId":"9c8a568e-7c1f-4369-8489-e86b54b71580","title":"Targeting mitochondrial dysfunction with elamipretide.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/35037146/","evidenceTier":"observational","summary":"PubMed-indexed journal article; review; research support, non-u.s. gov't examining targeting mitochondrial dysfunction with elamipretide. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"Chukwuemeka Obi; Alexander T Smith; Gregory J Hughes; Adedayo A Adeboye","publishingOrg":"Heart failure reviews","publicationYear":2022,"doi":"10.1056/NEJMoa2025797","pubmedId":"35037146","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:17.424Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1056/nejmoa2025797","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:17.424Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"mechanistic","extractionPayload":{"sourceStrength":{"grade":"B","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Journal Article; Review; Research Support, Non-U.S. Gov't"},"provenancePayload":{"doi":"10.1056/NEJMoa2025797","pmid":"35037146","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:17.424Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"5e089188-e175-55e5-b324-55af5df5c480","peptideId":"9c8a568e-7c1f-4369-8489-e86b54b71580","title":"Potential Therapeutic Candidates for Age-Related Macular Degeneration (AMD).","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/34572131/","evidenceTier":"observational","summary":"PubMed-indexed journal article; review examining potential therapeutic candidates for age-related macular degeneration (amd). Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"Sonali Nashine","publishingOrg":"Cells","publicationYear":2021,"doi":"10.1167/iovs.11-7524","pubmedId":"34572131","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:17.424Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1167/iovs.11-7524","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:17.424Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"mechanistic","extractionPayload":{"sourceStrength":{"grade":"B","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Journal Article; Review"},"provenancePayload":{"doi":"10.1167/iovs.11-7524","pmid":"34572131","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:17.424Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"10d1fdae-d35f-5ac5-8656-fd9c4d19e599","peptideId":"9c8a568e-7c1f-4369-8489-e86b54b71580","title":"Mitochondrial protein interaction landscape of SS-31.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/32554501/","evidenceTier":"observational","summary":"PubMed-indexed journal article; research support, n.i.h., extramural; research support, non-u.s. gov't examining mitochondrial protein interaction landscape of ss-31. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"Juan D Chavez; Xiaoting Tang; Matthew D Campbell; Gustavo Reyes; Philip A Kramer; Rudy Stuppard; Andrew Keller; Huiliang Zhang; Peter S Rabinovitch; David J Marcinek; James E Bruce","publishingOrg":"Proceedings of the National Academy of Sciences of the United States of America","publicationYear":2020,"doi":"10.1101/2020.01.02.893362","pubmedId":"32554501","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:17.424Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1101/2020.01.02.893362","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:17.424Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"mechanistic","extractionPayload":{"sourceStrength":{"grade":"C","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't"},"provenancePayload":{"doi":"10.1101/2020.01.02.893362","pmid":"32554501","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:17.424Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"8e676989-1e65-55a9-b367-aae006b8b5aa","peptideId":"9c8a568e-7c1f-4369-8489-e86b54b71580","title":"Elamipretide (SS-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/31747905/","evidenceTier":"animal","summary":"PubMed-indexed journal article examining elamipretide (ss-31) improves mitochondrial dysfunction, synaptic and memory impairment induced by lipopolysaccharide in mice. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"Weixing Zhao; Zhipeng Xu; Jiangbei Cao; Qiang Fu; Yishuang Wu; Xiaoying Zhang; Yue Long; Xuan Zhang; Yitian Yang; Yunfeng Li; Weidong Mi","publishingOrg":"Journal of neuroinflammation","publicationYear":2019,"doi":"10.1186/1742-2094-9-106","pubmedId":"31747905","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:17.424Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1186/1742-2094-9-106","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:17.424Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"animal_in_vivo","extractionPayload":{"sourceStrength":{"grade":"C","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Journal Article"},"provenancePayload":{"doi":"10.1186/1742-2094-9-106","pmid":"31747905","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:17.424Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"f13c96ef-17c6-57a7-8292-75d5f84c8968","peptideId":"9c8a568e-7c1f-4369-8489-e86b54b71580","title":"Novel cell-penetrating peptide targeting mitochondria.","sourceUrl":"https://pubmed.ncbi.nlm.nih.gov/26195590/","evidenceTier":"laboratory","summary":"PubMed-indexed journal article examining novel cell-penetrating peptide targeting mitochondria. Machine-staged source candidate; findings and limitations require accountable review before publication.","authors":"Carmine Pasquale Cerrato; Marco Pirisinu; Efstathios Nikolaos Vlachos; Ülo Langel","publishingOrg":"FASEB journal : official publication of the Federation of American Societies for Experimental Biology","publicationYear":2015,"doi":"10.1096/fj.14-269225","pubmedId":"26195590","jurisdiction":null,"dateAccessed":"2026-09-09T11:41:17.424Z","editorialNotes":"Machine-staged candidate; no human approval asserted.","sourceType":"peer_reviewed_research","claimSupported":null,"supportNature":null,"qualification":null,"verificationStatus":"verified","publicationStatus":"published","addedById":null,"machineActor":"codex-governed-profile-batch-10-2026-09-09","reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","canonicalSourceIdentity":"doi:10.1096/fj.14-269225","sourceIdentityId":null,"sourceStatus":"active","sourceContentHash":null,"sourceVersion":1,"retrievedAt":"2026-09-09T11:41:17.424Z","retrievalProvider":"NCBI PubMed","retrievalPayloadRef":null,"evidenceLane":"in_vitro","extractionPayload":{"sourceStrength":{"grade":"C","version":"WPF-ESR-1.0","provisional":true},"publicationTypes":"Journal Article"},"provenancePayload":{"doi":"10.1096/fj.14-269225","pmid":"26195590","provider":"NCBI PubMed"},"validationGates":{"pmidResolved":true,"humanReviewed":false,"identityResolved":true,"publicationApproved":false},"engineState":"candidate","engineRunId":null,"createdAt":"2026-09-09T11:41:17.424Z","updatedAt":"2026-09-09T19:33:05.147Z"}],"regulatory":[{"id":"e36f0d7f0b9899a574a9cb3ee965f966","peptideId":"9c8a568e-7c1f-4369-8489-e86b54b71580","jurisdiction":"European Union","status":"not_approved","approvedIndication":null,"rationale":"EMA orphan designation is not marketing authorization; no EU marketing authorization was identified in the reviewed official record.","sourceTitle":"EMA orphan designation EU/3/21/2430","sourceUrl":"https://www.ema.europa.eu/en/medicines/human/orphan-designations/eu-3-21-2430","dateChecked":"2026-09-09T11:45:21.643Z","reviewDueAt":"2027-03-08T11:45:21.643Z","enteredById":null,"reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","publicationStatus":"published","factualObservationId":null,"createdAt":"2026-09-09T11:45:21.643Z","updatedAt":"2026-09-09T19:33:05.147Z"},{"id":"abe687280d0b527f379692d1e376579f","peptideId":"9c8a568e-7c1f-4369-8489-e86b54b71580","jurisdiction":"United States","status":"approved","approvedIndication":"Improve muscle strength in adults and pediatric patients with Barth syndrome weighing at least 30 kg.","rationale":"FDA granted accelerated approval to Forzinity on 2025-09-19; continued approval may depend on confirmatory evidence.","sourceTitle":"FDA accelerated approval announcement","sourceUrl":"https://www.fda.gov/news-events/press-announcements/fda-grants-accelerated-approval-first-treatment-barth-syndrome","dateChecked":"2026-09-09T11:45:21.643Z","reviewDueAt":"2027-03-08T11:45:21.643Z","enteredById":null,"reviewedById":"0bf5b853-ea8b-4aa3-bffe-2af0fdd75150","publicationStatus":"published","factualObservationId":null,"createdAt":"2026-09-09T11:45:21.643Z","updatedAt":"2026-09-09T19:33:05.147Z"}],"claims":[],"correctionHistory":[],"boundaries":{"observationsAreEvidence":false,"completionIsPublicationApproval":false,"medicalAdvice":false}}